Acción BETR BETTERLIFE PHARMA INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas BetterLife Pharma Inc. Canadian Securities Exchange

Acciones

BETR

CA08772P2026

Mercado cerrado - Canadian Securities Exchange
Otros sitios de cotización
 16:50:44 15/05/2024 		Varia. Cinco días. Varia. 1 de enero.
0,125 CAD 0,00 % Gráfico intradía de BetterLife Pharma Inc. -3,85 % +108,33 %
14/05 BetterLife obtiene excelentes datos de seguridad cardiopulmonar animal para BETR-001 oral CI
01/05 BetterLife Pharma avanza en los estudios IND para BETR-001 MT

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
BetterLife Announces Intent to Complete Private Placement of Units
BetterLife Announces Intent to Complete Private Placement of Units
BetterLife Pharma Inc. announced that it expects to receive CAD 0.5 million in funding
BetterLife Pharma Advances IND-enabling Studies For BETR-001
BetterLife Advances BETR-001 IND-enabling Studies
BetterLife Advances BETR-001 IND-enabling Studies
BetterLife Pharma Inc. Advances BETR-001 IND-Enabling Studies
BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
BetterLife Pharma Inc. announced that it has received CAD 1.168 million in funding
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University
BetterLife Pharma Inc. announced that it expects to receive CAD 0.1 million in funding
BetterLife Pharma Inc. announced that it has received CAD 0.065 million in funding
BetterLife Closes Convertible Debentures For Further Development of BETR-001
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción BETRF
  4. Acción BETR
  5. Noticias BetterLife Pharma Inc.
  6. Otros idiomas